Summary
- Current Price
- As of today, ZVRA price is $10.18, down -7.20% on
- Current Price All-Time High
- ZVRA price is currently -97.57% below its historical high of $418.40 set on
- Market Cap
- ZVRA current market cap is $605M, up +15.50% over the past 365 days
- PE Ratio
- ZVRA current PE ratio is 10.98
- Revenue
- ZVRA current annual revenue is $106.47M, up +350.91% year-over-year
- Next Earnings
- The next earnings release for ZVRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Zevra Therapeutics, Inc. |
| Ticker | NASDAQ: ZVRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | zevra.com |
| Employees | 59 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $10.18 | |
| Price, 1D Change | -7.20% | |
| $605M | ||
| - | ||
| 10.98 | ||
| 0.85 | ||
| $106.47M | ||
| Revenue, 1Y Change | +350.91% | |
| $1.35 | ||
| EPS, 1Y Change | +159.39% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:16 | |
| Next Split | N/A | N/A |
| Last Ticker Change | KMPH | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $1.35 | ||
| EPS Estimate | $1.17 | N/A |
| EPS Est. Change | -13.89% | N/A |
| $106.47M | ||
| Revenue Estimate | $153.29M | N/A |
| Revenue Est. Change | +43.97% | N/A |
| Current Price | $10.18 | |
| Price Target | $24.00 | - |
| Price Tgt. Change | +135.76% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.93 | -$2.28 | -18.12% | |
| $1.16 | $1.35 | +16.80% | |
| $1.17 | N/A | -13.89% | |
| $1.08 | N/A | -20.53% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $20.51M | $23.61M | +15.10% | |
| $100.38M | $106.47M | +6.07% | |
| $153.29M | N/A | +43.97% | |
| $177.71M | N/A | +66.91% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $10.18 | |
| $10.55 | ||
| $11.38 | ||
| $10.89 | ||
| $11.61 | ||
| -$0.26 | ||
| 0.85 | ||
| $0.45 | ||
| 29.74 | ||
| 41.13% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $106.47M | ||
| $1.35 | ||
| $85.93M | ||
| 80.71% | ||
| -$4.23M | ||
| -3.98% | ||
| $77.59M | ||
| 72.87% | ||
| -$179.00K |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.41 | ||
| 5.68 | ||
| 5.63 | ||
| - | ||
| 6 | ||
| 1.81 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 10.98 | ||
| 4.44 | ||
| 2.78 | ||
| 9.49 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $154.66M | ||
| $191.01M | ||
| $284.73M | ||
| $223.01M | ||
| $130.07M | ||
| $39.28M | ||
| $63.21M | ||
| $419.00K | ||
| $2.48M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $28.89M | ||
| $90.17M | ||
| $20.54M | ||
| $0.00 | ||
| $4.05M | ||
| $0.00 | ||
| $3.45M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$1.60M | ||
| $18.13M | ||
| $12.06M | ||
| $835.00K | ||
| -$2.43M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Citizens | → | |
| Guggenheim | → | |
| Canaccord Genuity | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Maxim Group | → | |
| Guggenheim | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ZVRA
FAQ
- What is the ticker symbol for Zevra Therapeutics, Inc.?
- The ticker symbol for Zevra Therapeutics, Inc. is NASDAQ:ZVRA
- Does Zevra Therapeutics, Inc. pay dividends?
- No, Zevra Therapeutics, Inc. does not pay dividends
- What sector is Zevra Therapeutics, Inc. in?
- Zevra Therapeutics, Inc. is in the Healthcare sector
- What industry is Zevra Therapeutics, Inc. in?
- Zevra Therapeutics, Inc. is in the Biotechnology industry
- What country is Zevra Therapeutics, Inc. based in?
- Zevra Therapeutics, Inc. is headquartered in United States
- When did Zevra Therapeutics, Inc. go public?
- Zevra Therapeutics, Inc. initial public offering (IPO) was on April 16, 2015
- Is Zevra Therapeutics, Inc. in the S&P 500?
- No, Zevra Therapeutics, Inc. is not included in the S&P 500 index
- Is Zevra Therapeutics, Inc. in the NASDAQ 100?
- No, Zevra Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Zevra Therapeutics, Inc. in the Dow Jones?
- No, Zevra Therapeutics, Inc. is not included in the Dow Jones index
- When was Zevra Therapeutics, Inc. last earnings report?
- Zevra Therapeutics, Inc.'s most recent earnings report was on August 5, 2026
- When does Zevra Therapeutics, Inc. report earnings?
- The next expected earnings date for Zevra Therapeutics, Inc. is November 4, 2026
Data Sources & References
- ZVRA Official Website zevra.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1434647/000143464726000011/0001434647-26-000011-index.htm
- ZVRA Profile on Yahoo Finance finance.yahoo.com/quote/ZVRA
- ZVRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zvra
